BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang FK, Lin CC, Huang TC, Weng KP, Liu PY, Chen YY, Wang HP, Ger LP, Hsieh KS. Reappraisal of the prostaglandin E1 dose for early newborns with patent ductus arteriosus-dependent pulmonary circulation. Pediatr Neonatol 2013;54:102-6. [PMID: 23590954 DOI: 10.1016/j.pedneo.2012.10.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Enesei M, Takács L, Tormási E, Tóthné Rácz A, Róka Z, Kádár M, Kardos Z. Preparation and Chiral HPLC Separation of the Enantiomeric Forms of Natural Prostaglandins. Chemistry 2020;2:727-41. [DOI: 10.3390/chemistry2030047] [Reference Citation Analysis]
2 Hong Z, Cabrera JA, Mahapatra S, Kutty S, Weir EK, Archer SL. Activation of the EGFR/p38/JNK pathway by mitochondrial-derived hydrogen peroxide contributes to oxygen-induced contraction of ductus arteriosus. J Mol Med (Berl) 2014;92:995-1007. [PMID: 24906456 DOI: 10.1007/s00109-014-1162-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
3 Hao F, Guo H, Zhong J, Geng Q, Yang Y, Chen B, Guo C. Effects of Prostaglandin E1 on Patients Undergoing Major Gastrointestinal Surgery. Ann Surg 2018;267:759-65. [PMID: 28121679 DOI: 10.1097/SLA.0000000000002152] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Akkinapally S, Hundalani SG, Kulkarni M, Fernandes CJ, Cabrera AG, Shivanna B, Pammi M. Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions. Cochrane Database Syst Rev 2018;2:CD011417. [PMID: 29486048 DOI: 10.1002/14651858.CD011417.pub2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
5 Alphonso N, Angelini A, Barron DJ, Bellsham-revell H, Blom NA, Brown K, Davis D, Duncan D, Fedrigo M, Galletti L, Hehir D, Herberg U, Jacobs JP, Januszewska K, Karl TR, Malec E, Maruszewski B, Montgomerie J, Pizzaro C, Schranz D, Shillingford AJ, Simpson JM; (Chaiman HLHS Guidelines Task Force). Guidelines for the management of neonates and infants with hypoplastic left heart syndrome: The European Association for Cardio-Thoracic Surgery (EACTS) and the Association for European Paediatric and Congenital Cardiology (AEPC) Hypoplastic Left Heart Syndrome Guidelines Task Force. European Journal of Cardio-Thoracic Surgery 2020;58:416-99. [DOI: 10.1093/ejcts/ezaa188] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
6 Aykanat A, Yavuz T, Özalkaya E, Topçuoğlu S, Ovalı F, Karatekin G. Long-Term Prostaglandin E1 Infusion for Newborns with Critical Congenital Heart Disease. Pediatr Cardiol 2016;37:131-4. [PMID: 26260095 DOI: 10.1007/s00246-015-1251-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
7 Mitchell LJ, Mayer CA, Mayer A, Di Fiore JM, Shein SL, Raffay TM, MacFarlane PM. Caffeine prevents prostaglandin E1-induced disturbances in respiratory control in neonatal rats: implications for infants with critical congenital heart disease. Am J Physiol Regul Integr Comp Physiol 2020;319:R233-42. [PMID: 32579854 DOI: 10.1152/ajpregu.00316.2019] [Reference Citation Analysis]
8 Alhussin W, Verklan MT. Complications of Long-Term Prostaglandin E1 Use in Newborns With Ductal-Dependent Critical Congenital Heart Disease. J Perinat Neonatal Nurs 2016;30:73-9. [PMID: 26813395 DOI: 10.1097/JPN.0000000000000152] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
9 Boos V, Tietze A, Berger F, Bührer C. Therapeutic Hypothermia After Perinatal Asphyxia in Infants With Severe, Ductal-Dependent Congenital Heart Disease*: . Pediatric Critical Care Medicine 2019;20:457-65. [DOI: 10.1097/pcc.0000000000001878] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Cucerea M, Simon M, Moldovan E, Ungureanu M, Marian R, Suciu L. Congenital Heart Disease Requiring Maintenance of Ductus Arteriosus in Critically Ill Newborns Admitted at a Tertiary Neonatal Intensive Care Unit. J Crit Care Med (Targu Mures) 2016;2:185-91. [PMID: 29967858 DOI: 10.1515/jccm-2016-0031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
11 Mitchell L, MacFarlane PM. Mechanistic actions of oxygen and methylxanthines on respiratory neural control and for the treatment of neonatal apnea. Respir Physiol Neurobiol 2020;273:103318. [PMID: 31626973 DOI: 10.1016/j.resp.2019.103318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
12 Higgins KL, Buck ML. Caffeine Citrate for the Prevention of Apnea Associated With Alprostadil Infusions. J Pediatr Pharmacol Ther 2020;25:235-40. [PMID: 32265607 DOI: 10.5863/1551-6776-25.3.235] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Vari D, Xiao W, Behere S, Spurrier E, Tsuda T, Baffa JM. Low-dose prostaglandin E1 is safe and effective for critical congenital heart disease: is it time to revisit the dosing guidelines? Cardiol Young 2021;31:63-70. [PMID: 33140712 DOI: 10.1017/S1047951120003297] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]